Professor Christopher Etherton-Beer

Started at UWA: 2004

Improving the lives of those with dementia

There is sparse guidance relating to managing medications to treat other chronic conditions for people living with dementia. My goal is to change this.
Professor Christopher Etherton-Beer

Professor Etherton-Beer is a geriatrician and a clinical pharmacologist at Royal Perth Hospital and chairs the Western Australian Therapeutics Advisory Group. He serves on Australia’s Pharmaceutical Benefits Advisory Committee (PBAC). He also chairs the Drug Utilisation Sub-committee of PBAC, which has a national focus of excellence in collecting, analysing and interpreting data on the utilisation of medicines in Australia for use by the PBAC.

Professor Etherton-Beer is currently involved in running several research studies that are looking at improving medication outcomes in older people. At UWA, he co-ordinates the University’s geriatric medicine teaching within the Medical School. He remains an active clinician, and at Royal Perth Bentley Group is the Medical Co-Director of the Medical Division. 

His research has led him to develop several education and organisational resource tools.  He has designed a comprehensive online health education program, known as e-ageing. This program was initially designed to assist medical students learn about common age related conditions.  However, this program is now being accessed by health professionals and students from around Australia and the world.

Across the globe people are living longer. With older people expected to make up nearly a quarter of Australia’s population by 2056, these resources are needed now more than even to assist health professionals to optimise health services for older people.


award Created with Sketch.

Senior Advocate Award, 2015

008-trophy Created with Sketch.

Research award for Best Completed Research Abstract at SimHealth, 2016

medal Created with Sketch.

Joint winner, Outstanding Contribution to Student Learning, UWA Faculty of Medicine, Dentistry and Health Science Excellence in Teaching Awards, 2017



2018 – 2020

National Health and Medical Research Council

  • BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • Almeida, O., Etherton-Beer, C., Flicker, L. and Ford, A.

National Health and Medical Research Council

  • Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • Etherton-Beer, C., Clifford, R. & Page, A.

2018 – 2019

WA Health Promotion Foundation Healthway

  • Strengthening Consumer Voice: Using stories to shift mental illness stigma
  • Seubert, L., Brand, G., Clifford, R. & Etherton-Beer, C.


WA Department of Health

  • MHRIF Round 21 - Christopher Etherton-Beer
  • Etherton-Beer, C.

Worldwide Universities Network

  • Sustainability Fund Grant - A Social Care Approach to Ageing: Extending the WUN global initiative promoting meaningful engagement of persons with advanced dementia ageing in supported living environments
  • Baldassar, L. & Etherton-Beer, C.

Pharmaceutical Society of Western Australia

  • The PHarmacie-4 Framework: Using risk stratification and care coordination to bridge the care continuum gap
  • Clifford, R., Criddle, D., Etherton-Beer, C., Murray, K., Sanfilippo, F. & Smart, P.

2017 – 2021

National Health and Medical Research Council

  • Reaching the tenth decade of life in Australia – A 20-year longitudinal study of older men
  • Flicker, L., Almeida, O., Etherton-Beer, C., McCaul, K. & Yeap, B.

2017 – 2019

WA State Health Research Advisory Council

  • RTP - Round 11 - The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) study for older hospital inpatients
  • Etherton-Beer, C., Clifford, R. & Page, A.

2014 – 2018

University of Sydney

  • Centre of Research Excellence in Medicines and Ageing
  • Preen, D. & Etherton-Beer, C.

National Health and Medical Research Council

  • An Australasian, multi-centre, randomized, double-blind, placebo-controlled trial of the efficacy of fluoxetine in improving functional recovery after acute stroke / Assessment of FluoxetINe In sTroke recoverY (AFFINITY)
  • Hankey, G., Almeida, O., Etherton-Beer, C., Flicker, L. & Ford, A.

Contact Professor Christopher Etherton-Beer